Rob Gronkowski Is “Back in The Game” with CBDMEDIC™
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200422005882/en/
Gronkowski attributes his use of CBDMEDIC as a key factor in his decision to return to playing football, stating, “I left the game last year after realizing that my body had taken a beating and needed to recover. I’ve taken the recovery process seriously and CBDMEDIC has played a big role in my recovery. Now I’m glad to share that I’m back in the game!” Gronkowski added, “As a result of my personal experience I have advocated for the use of CBD products to be available to both the public and professional athletes and am glad to see changes in policy with sports organizations across the board.”
The use of CBD, an ingredient in hemp extract, in topical medications has experienced a gradual liberalization over the past years as a result of US federal government legislation, the distribution of products by major US retail chains, as well as the allowance by many professional sports leagues.
Abacus’ CBDMEDIC products contain active pharmaceutical ingredients as well as hemp extract. The 2018 Farm Bill, passed in
Abacus and Gronkowski have welcomed the significant changes made across professional sports over the past years that reflect the changing attitudes and awareness in the use of hemp extract and CBD to address a variety of health issues including pain management, which is a positive indicator for the future role of CBD in professional sports.
Abacus and Gronkowski have affirmed that the commercial relationship between the parties continues to be effective following Gronkowski’s decision to return to professional football.
About SURVIVE & THRIVE
CBDMEDIC™ has teamed up with a cast of celebrities including 3X Pro Football Champion
#SurviveandThrive
Link to SURVIVE & THRIVE here: https://bit.ly/34LKsqC
About CBDMEDIC
Launched in 2019, CBDMEDIC offers a line of topical pain medications that combine naturally-derived pain-relieving active OTC drug ingredients with 100% natural emollients (skin softening ingredients), essential oils, and broad-spectrum THC-free, CBD-rich hemp oil to create unique formulations that work with the body for powerful, targeted, and effective pain relief.
Forward-Looking Statements
This news release contains forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities legislation. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company's control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements.
The forward-looking statements contained in this news release include, without limitation, statements relating to the execution of the Company’s growth strategy are based on management's current expectations and are subject to a number of risks, uncertainties and assumptions, including assumptions regarding the Company's ability to efficiently operate its business, market and economic conditions, business prospects or opportunities, future plans and strategies, anticipated events and trends, and regulatory changes that may affect the Company and its customers and industry. There can be no assurance that actual results will not differ materially from those expressed or implied in forward looking statements. Undue reliance should not be placed on forward-looking statements. Additional information about these risks, uncertainties and assumptions is contained under "Risk Factors and Uncertainties" in the Company's annual information form dated
About
Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across
To learn more about Abacus, visit www.abacushp.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200422005882/en/
For further information:
Email: [email protected]
Or
Email: [email protected]
Office: 1.416.479.9547
Source:
AM Best Affirms Credit Ratings of Hamilton Re, Ltd. and Hamilton Insurance Designated Activity Company
Cartwright unveils hazard pay proposal for essential front line workers
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News